Trombositopenia Dokter Terbaik di Israel - TOP-13 dokter

Biaya konsultasi tersedia berdasarkan permintaan.

• Detail dokter dan spesialisasi sedang dikonfirmasi.
• Informasi tambahan mengenai kredensial dan pengalaman sedang disusun.
• Silakan periksa kembali segera untuk melihat profil yang lebih rinci.

Dr. El Hasid telah melakukan lebih dari 300 transplantasi sumsum tulang dan darah tali pusat di Rumah Sakit Anak Dana Dwek. Beliau mengepalai departemen Onkohematologi dan Onkologi Anak di sana.

• Berespesialisasi dalam transplantasi sumsum tulang dan darah tali pusat khusus untuk anak-anak
• Menempuh pelatihan di City of Hope Hospital yang prestisius di Los Angeles
• Penulis lebih dari 50 publikasi ilmiah dan 40 laporan konferensi
• Anggota American Association for Hematology dan Israeli Society for Pediatric Hematooncology

Dr. Ram telah melakukan beberapa ratus transplantasi sel punca untuk kelainan darah seperti trombositopenia di Sourasky Medical Center (Ichilov). Beliau memiliki sertifikasi dewan rangkap tiga dalam Penyakit Dalam, Hematologi, dan Onkologi Medis.

• Menyelesaikan pelatihan fellowship dalam Hematologi dan Onkologi di New York Medical College
• Menerbitkan lebih dari 30 artikel ilmiah tentang penyakit darah dan onkologi
• Menulis bab dalam buku teks medis
• Menyelesaikan residensi di State University of New York di Brooklyn

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Spesialisasi dalam Transplantasi Sumsum Tulang – Dr. Shapira membawa keahlian luas dalam menangani kasus Trombositopenia.

• Lulus dari Fakultas Kedokteran Universitas Ibrani pada tahun 1999
• Spesialisasi dalam penyakit dalam di Hadassah Medical Center
• Dokter senior dalam Transplantasi Sumsum Tulang di Hadassah
• Berbicara dalam bahasa Inggris dan Ibrani

Dr. Dror Levin memimpin departemen hematologi onkologi anak di Sourasky Medical Center, spesialis dalam gangguan darah pada anak.

• Direktur hematologi onkologi anak di Sourasky Medical Center
• Ahli dalam mengobati gangguan koagulasi darah pada anak
• Spesialisasi dalam hematologi dan onkologi anak di Schneider Children's Medical Center
• Anggota ISPHO – Asosiasi hemato-onkologi anak Israel
• Mempelajari onkologi tulang dan jaringan lunak di Rizzoli Orthopaedic Institute di Italia

Dr. Kirshner berkontribusi aktif dalam memajukan hematologi melalui uji klinis, termasuk uji fase III untuk kanker prostat yang resistan terhadap pengebirian.

• Menyelesaikan pelatihan fellowship hematologi di Montefiore Medical Center
• Bermitasi dalam pendekatan pengobatan yang berfokus pada penelitian
• Memiliki latar belakang luas dalam penyakit dalam dan onkologi

Dr. Fredi Aviv memiliki 31 tahun pengalaman spesialisasi dalam onkohematologi di Sourasky Medical Center.

• Menspesialisasi dalam diagnosis dan pengobatan kelainan darah
• Pengalaman jangka panjang di pusat medis terkemuka di Israel
• Mendedikasikan diri untuk memberikan perawatan pribadi bagi kondisi hematologi yang kompleks

Dr. Gal Goldstein adalah spesialis hemato-onkologi pediatrik yang terdaftar di Forbes di Hadassah Medical Center, yang diakui sebagai salah satu dokter terbaik di Israel.

• Kepala Onkologi dan Hemato-Onkologi Pediatrik di Rumah Sakit Hadassah Ein Kerem
• Spesialisasi dalam hemato-onkologi pediatrik selama lebih dari 20 tahun
• Ahli dalam retinoblastoma dan kedokteran presisi
• Anggota dari berbagai asosiasi onkologi pediatrik internasional
• Melakukan transplantasi sumsum tulang haploidentik

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.